[Form 4] ACCO BRANDS Corp Insider Trading Activity

Rhea-AI Filing Summary

ACCO BRANDS Corp (ACCO) reporting person James M. Dudek, SVP, Corporate Controller and CAO, received three grants of Restricted Stock Units (RSUs) on 09/10/2025 under the company's incentive plan. The grants consist of 365.3 RSUs vesting on 03/14/2026, 340.4 RSUs vesting on 03/12/2027, and 357.7 RSUs vesting on 03/11/2028. Dividend equivalent RSUs of 365.3 are included in the first grant. Each RSU represents the right to one share of common stock if the reporting person remains employed through the applicable vesting date. Following these transactions the reported beneficial ownership amounts for each award line are 19,700; 18,357.3; and 19,294.2 shares respectively. The Form 4 was signed by an attorney-in-fact on 09/12/2025.

Positive

• Retention-focused compensation: Time-based RSUs align executive incentives with shareholder value over 2026-2028.
• Dividend equivalents included: The 2026 award includes dividend-equivalent RSUs, preserving value for the reporting person until vesting.

Negative

• Potential future dilution: Conversion of RSUs into common stock will increase share count when they vest.
• No grant rationale disclosed: Form 4 does not provide context on board approval, performance conditions, or impact on total outstanding shares.

Insights

Securities Analyst

TL;DR: Executive received time-based RSU awards; this is routine compensation, not an immediate cash transaction.

The reporting shows three time-based RSU grants awarded on 09/10/2025 to the issuer's SVP and CAO. Vesting dates span 2026 to 2028 and include dividend-equivalent units for the 2026 award. These are compensation-driven equity awards that increase potential future dilution when they vest and convert into common shares. There is no exercise price and no sale or purchase of common stock reported here, so no immediate transfer of shares or proceeds occurred. The filings are consistent with standard executive incentive arrangements and do not by themselves indicate a change in control, disposition, or liquidity event.

Corporate Governance Expert

TL;DR: Grants reflect standard retention and incentive structure; materiality is low absent other events.

The Form 4 documents issuance of RSUs under the company incentive plan subject to continued employment and possible acceleration per plan terms. The inclusion of dividend-equivalent RSUs shows alignment with total-share-value compensation practices. From a governance perspective, these awards should have been authorized by the board/compensation committee under existing plans; the Form 4 does not disclose committee approvals or grant rationale. Without additional context such as total outstanding shares or recent insider selling, these awards appear routine and governance concerns cannot be assessed from this filing alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dudek James

(Last) (First) (Middle)

C/O ACCO BRANDS CORPORATION

(Street)

LAKE ZURICH IL 60047

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ACCO BRANDS Corp [ ACCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Corp Controller and CAO

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units(1)	$0	09/10/2025		A		365.3(2)		03/14/2026	03/14/2026	Common Stock	365.3	$0	19,700	D
Restricted Stock Units(3)	$0	09/10/2025		A		340.4(2)		03/12/2027	03/12/2027	Common Stock	340.4	$0	18,357.3	D
Restricted Stock Units(4)	$0	09/10/2025		A		357.7(2)		03/11/2028	03/11/2028	Common Stock	357.7	$0	19,294.2	D

Explanation of Responses:

1. Restricted Stock Units (RSUs) granted under the Issuer's Incentive Plan. Each RSU represents the right to receive one share of the Issuer's common stock on March 14, 2026, provided the Reporting Person remains employed by the Issuer at that time, subject to acceleration as provided in said Plan.

2. Represents Restricted Stock Units (RSUs) acquired pursuant to the dividend equivalent provisions of the Reporting Person's earned and outstanding RSU awards.

3. Restricted Stock Units (RSUs) granted under the Issuer's Incentive Plan. Each RSU represents the right to receive one share of the Issuer's common stock on March 12, 2027, provided the Reporting Person remains employed by the Issuer at that time, subject to acceleration as provided in said Plan.

4. Restricted Stock Units (RSUs) granted under the Issuer's Incentive Plan. Each RSU represents the right to receive one share of the Issuer's common stock on March 11, 2028, provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as provided in said Plan.

	/s/ Kathryn D. Ingraham, Attorney-in-fact for James M. Dudek	09/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What RSU grants did ACCO insider James M. Dudek report on Form 4 (ACCO)?

The Form 4 reports three RSU grants on 09/10/2025: 365.3 RSUs vesting 03/14/2026 (includes dividend equivalents), 340.4 RSUs vesting 03/12/2027, and 357.7 RSUs vesting 03/11/2028.

Do these Form 4 entries show any stock sales or purchases for ACCO insider Dudek?

No. The entries are grants of Restricted Stock Units (RSUs) coded as acquisitions of derivative securities with $0 exercise price. No open-market sale or purchase of common stock is reported.

When will the reported RSUs for ACCO become shares if Dudek remains employed?

The RSUs convert to common stock on their respective vesting dates: 03/14/2026, 03/12/2027, and 03/11/2028, provided employment and plan terms are met.

How many shares are shown as beneficially owned following each reported RSU grant?

Following the reported transactions the Form 4 lists beneficial ownership amounts of 19,700, 18,357.3, and 19,294.2 for the three award lines respectively.

Who signed the Form 4 for James M. Dudek and when was it signed?

The Form 4 was signed by Kathryn D. Ingraham as attorney-in-fact for James M. Dudek on 09/12/2025.